Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infectionReport as inadecuate




Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection - Download this document for free, or read online. Document in PDF available to download.

Biological Procedures Online

, Volume 5, Issue 1, pp 43–52

Received: 10 December 2002Revised: 03 February 2003Accepted: 05 February 2003DOI: 10.1251-bpo45

Cite this article as: Bartlett, E.J., Cull, V.S., Mowe, E.N. et al. Biol. Proced. Online 2003 5: 43. doi:10.1251-bpo45

Abstract

Type I interferon IFN gene therapy modulates the immune response leading to inflammatory heart disease following cytomegalovirus CMV infection in a murine model of post-viral myocarditis. Efficacy of different immunisation protocols for the IFN constructs was influenced by the dose of DNA, subtype choice, combination use, pre-medication, and timing of DNA administration. Optimal efficacy was found with bupivacaine treatment prior to DNA inoculation of 200µgIFN DNA 14 days prior to virus challenge. Maximal antiviral and antimyocarditic effects were achieved with this vaccination schedule. Furthermore, inoculation of synergistic IFN subtypes demonstrated enhanced efficacy when delivered either alone or with CMVgB DNA vaccination in the CMV model. Thus naked DNA delivery of IFN provides an avenue of immunotherapy for regulating herpesvirus-induced diseases.

Indexing termsinterferons gene therapy cytomegalovirus DNA Published: February 17, 2003

Download to read the full article text



Author: Emmalene J. Bartlett - Vanessa S. Cull - Eva N. Mowe - Josephine P. Mansfield - Cassandra M. James

Source: https://link.springer.com/







Related documents